Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 10/17/22 → 8/23/25 |
Funding
- Cognition Therapeutics Incorporated: $117,860.00
A Randomized, Double-blind, Placebo-controlled, Phase 2, 6-month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects with Mild to Moderate Dementia with Lewy Bodies
- Jicha, Gregory (PI)